We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The U.S. Senate and House passed spending bills to fight the Zika virus within 24 hours of each other. The distinct measures both include HHS funding for vaccines, therapies and diagnostic tests. Read More
The European Medicines Agency recommendations for drug approvals saw a steady uptick in 2015, even as the number of new active substances fell slightly. Read More
The Secretary’s Advisory Committee on Human Research Protections is recommending that the FDA revise its informed consent waivers for cluster randomized trials to mirror HHS rules. Read More
The Senate Appropriations Committee unanimously approved a fiscal 2017 funding bill Thursday that would provide the FDA with $4.78 billion in total funding, around $100 million above the current funding level. Read More
The European Medicines Agency is providing guidance on how drugmakers can best incorporate patient-reported outcomes in developing oncology studies. Read More
The Secretary’s Advisory Committee on Human Research Protections is recommending revisions to the Common Rule that would provide further guidance on single IRB reviews. Read More